ARAhmed M. Refaat

Ahmed M. Refaat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ahmed M. Refaat has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Biofunctionalization of Selenium Nanoparticles with Moringa Oleifera Modulates Redox Balance and Inflammatory Responses in Experimental Hyperglycemia

    by Ranim Mohamed Nagy, Omnia Ibrahim Elshabrawy, Rania Talat Hamad, Mabrouk Attia Abd Eldaim, Ahmed M. Refaat

    Diabetes mellitus is associated with sustained oxidative stress and inflammation that drive progressive cellular and tissue dysfunction. Selenium is a key redox-regulating trace element; however, how phytochemical surface functionalization alters the biological performance of selenium-based nanomaterials remains insufficiently defined. This study comparatively evaluated selenium nanoparticles (SeNPs), Moringa oleifera-derived nanoparticles (MONPs), and M. oleifera-functionalized selenium nanoparticles (MO-SeNPs) in a streptozotocin-induced diabetic rat model. Diabetes induction resulted in hyperglycemia, elevated glycated hemoglobin (HbA1c), increased lipid peroxidation, enhanced pancreatic TNF-α levels, impaired antioxidant defenses, and marked pancreatic, hepatic, and renal tissue injury. All nanoformulations partially improved these parameters; however, MO-SeNPs produced the most consistent improvement in long-term glycemic control (HbA1c), redox balance, inflammatory markers, and tissue architecture. Notably, selenium-based nanomaterials exhibited context-dependent redox effects in non-diabetic animals, underscoring the importance of dose and disease state. Collectively, these findings demonstrate that phytochemical functionalization modulates the applied biochemical performance of selenium nanoparticles and supports biofunctionalization as an optimization strategy for redox-targeted nanomaterials.

  • Open Access

    Integrated pan-cancer multi-omics profiling and experimental validation identify LSM12 as a prognostic biomarker and candidate therapeutic target in human cancers

    by Muhammad Alaa Eldeen, Ahmed M. Refaat, Hebatallah Emam Mohammed Ahmed, Hesham M. Hassan, Mohamed Alshehri, Eman Fayad, Ibrahim Jafri, Dalal Sulaiman Alshaya, Nouf A. Babteen, Leena M. Sait, et al.

    RNA metabolism regulators remain insufficiently characterized across tumor types, despite the substantial expansion of multi-omics datasets. LSM12, a membe

  • Open Access

    Chitosan-Based Taurine Nanoparticles Alleviate Dexamethasone-Induced Pulmonary–Thyroid Axis Dysfunction via Redox–Inflammatory Signaling Modulation in Rats

    by Amany M. Hamed, Ahmed M. Refaat, Safaa S. Soliman, Dalia A. Elbahy, Rasha Abdeen Refaei, Alia K. H. Mahmoud, Ahmed S. Osman, Safaa Mohammed Elmahdy, Eman E. Ragab, Hany M. R. Abdel-Latif, et al.

    Dexamethasone induces systemic toxicity, including oxidative stress, inflammation, hematological disturbances, and organ damage, particularly in the lungs and thyroid. Taurine exhibits antioxidant and anti-inflammatory properties, but poor bioavailability limits its efficacy. Nanoparticle delivery may enhance stability and tissue targeting. This study aimed to evaluate the protective effects of taurine-loaded chitosan nanoparticles (Tau–CS NPs) against dexamethasone-induced tissue injury in rats. Forty-eight male Wistar rats were allocated into control, DEXA, DEXA + silymarin, DEXA + taurine, and DEXA + Tau–CS NPs groups. Tau–CS NPs were characterized by TEM, UV–vis, FTIR, encapsulation efficiency, and drug loading. Hematology, oxidative stress markers (CAT, SOD, GSH, MDA), thyroid hormones (T3, T4, TSH, calcitonin), protein profile, lung and thyroid histopathology, and MPO expression were assessed. Tau–CS NPs showed uniform spherical morphology (11–60 nm), high encapsulation (98.2%), and substantial loading (50.36%). Dexamethasone caused hematological, oxidative, thyroidal, and histological disturbances. Tau–CS NPs markedly restored hematological indices, antioxidant defenses, thyroid function, protein profile, and tissue architecture, outperforming free taurine and silymarin. MPO expression was significantly reduced, indicating decreased inflammation. Taurine nanoparticles effectively mitigate dexamethasone-induced systemic and organ-specific toxicity, offering improved bioavailability and targeted delivery, highlighting their therapeutic potential.

  • Immunorestorative effects of caraway and marjoram extracts on Th2-mediated inflammation in house dust mite–triggered asthma

    by Ahmed M. Refaat, Honyda S. Mohammed, Farouk Ali, Heba Mohamed, Rania Abdallah, Bahaa K.A. Abdel-Salam

  • Open Access

    Phase separation as an emerging regulatory framework in antibody class switching and genome stability

    by Ahmed M. Refaat, Hidetaka Shimizu, Takaaki Yasuhara

    The spatial and temporal organization of nuclear processes is increasingly interpreted through principles associated with liquid–liquid phase separation (LLPS), whereby multivalent interactions among proteins and nucleic acids generate dynamic, membraneless assemblies. In DNA repair, such assemblies have been proposed to coordinate damage sensing, signaling, and repair pathway choice; however, their causal contribution in physiological immune contexts remains under active investigation. Antibody class switch recombination (CSR) provides a stringent immunological model in which to examine these concepts, as activated B lymphocytes must efficiently rejoin programmed DNA double-strand breaks (DSBs) across long genomic distances while suppressing aberrant chromosomal rearrangements. Emerging evidence indicates that CSR involves dynamic RNA–protein assemblies enriched for 53BP1, heterogeneous nuclear ribonucleoproteins such as HNRNPU, and transcription-associated RNA scaffolds, with properties consistent with biomolecular condensation. These assemblies are proposed to function as a CSR-specific regulatory hub—or “switchosome”—that concentrates non-homologous end joining factors, enforces repair pathway choice, and integrates transcription, RNA structure, and chromatin architecture at immunoglobulin heavy-chain ( IgH ) switch regions. Rather than treating LLPS as universally established, this review critically evaluates experimental evidence supporting condensate-like behavior in CSR-associated repair compartments, distinguishing demonstrated mechanisms from LLPS-consistent or speculative models. We further discuss how disruption of condensate dynamics—either through impaired assembly or pathological stabilization—can compromise repair fidelity, contributing to immunodeficiency and B cell lymphomagenesis. By positioning CSR as a paradigm for studying higher-order nuclear organization during programmed genome rearrangements, this review highlights how condensate-based regulation may contribute to immune diversification and genome stability.

  • Open Access

    Nano-Melittin Attenuates Zearalenone-Induced Ovarian Toxicity by Modulating the Inflammatory–Apoptotic–Steroidogenic Axis in Rats

    by Rasha Abdeen Refaei, Ahmed M. Refaat, Amany M. Hamed, Noha A. R. Fouda, Zeyad Elsayed Eldeeb Mohana, Rawia M. Ibrahim, Ereen Kondos Naeem, Gehad S. Mokhtar, Pierre E. Mehanny, Sherine Nabil Mohammed Fawzy, et al.

    Background: Zearalenone (ZEA) is a potent estrogenic mycotoxin that adversely affects the female reproductive system, causing hormonal imbalance, uterine enlargement, structural changes in the reproductive tract, and reduced fertility. This study evaluated the protective effects of melittin-loaded chitosan nanoparticles (MEL-NPs) against ZEA-induced ovarian toxicity in female rats. Methods: Forty-eight adult female Wistar rats (180–200 g) were divided into four groups: Control, ZEA, ZEA + MEL, and ZEA + MEL-NPs. ZEA (2.7 mg/kg b.w.) was administered orally twice weekly for two weeks. MEL and MEL-NPs (40 μg/kg b.w.) were given orally three times weekly for one month. Serum biochemical parameters were measured, and ovarian tissues were examined grossly and histopathologically. qRT-PCR was performed to assess mRNA expression of inflammatory markers (TNF-α, IL-6, IL-1β), apoptotic marker (Caspase-3), and steroidogenic enzyme (CYP19A1). Results: ZEA exposure induced significant ovarian toxicity, evidenced by increased TNF-α, IL-6, IL-1β, LH, FSH, CA-125, and Caspase-3, along with decreased progesterone, antioxidant capacity, and CYP19A1 expression. Histopathology revealed ovarian atrophy, follicular degeneration, and fibrosis. Treatment with MEL-NPs markedly reversed these alterations, normalizing cytokine and hormonal profiles, restoring CYP19A1 expression, and improving ovarian morphology. MEL-NPs demonstrated superior protective effects compared to free MEL. Conclusions: MEL-NPs effectively ameliorate ZEA-induced ovarian toxicity by restoring hormonal balance, enhancing antioxidant defense, and reducing inflammation and apoptosis. These findings suggest that MEL-NPs could be a promising therapeutic strategy for preventing mycotoxin-induced ovarian dysfunction.